| Product Code: ETC7538920 | Publication Date: Sep 2024 | Product Type: Market Research Report | ||
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India car t-cell immunotherapy market import shipments experienced a downward trend from 2020 to 2024, as indicated by a negative CAGR of -1.7%. The growth rate further declined notably by -25.5% between 2023 and 2024, reflecting a significant contraction in market activity during that period.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India CAR T-Cell Immunotherapy Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India CAR T-Cell Immunotherapy Market Revenues & Volume, 2021 & 2031F |
3.3 India CAR T-Cell Immunotherapy Market - Industry Life Cycle |
3.4 India CAR T-Cell Immunotherapy Market - Porter's Five Forces |
3.5 India CAR T-Cell Immunotherapy Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 India CAR T-Cell Immunotherapy Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 India CAR T-Cell Immunotherapy Market Revenues & Volume Share, By Target Antigen, 2021 & 2031F |
3.8 India CAR T-Cell Immunotherapy Market Revenues & Volume Share, By End Users, 2021 & 2031F |
4 India CAR T-Cell Immunotherapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in India |
4.2.2 Growing investments in healthcare infrastructure and research and development |
4.2.3 Rising awareness about immunotherapy and its benefits |
4.3 Market Restraints |
4.3.1 High cost associated with CAR T-cell therapy |
4.3.2 Limited accessibility to advanced healthcare facilities in certain regions of India |
4.3.3 Regulatory challenges and approval processes for innovative therapies |
5 India CAR T-Cell Immunotherapy Market Trends |
6 India CAR T-Cell Immunotherapy Market, By Types |
6.1 India CAR T-Cell Immunotherapy Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 India CAR T-Cell Immunotherapy Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 India CAR T-Cell Immunotherapy Market Revenues & Volume, By Allogeneic CAR T-Cells, 2021- 2031F |
6.1.4 India CAR T-Cell Immunotherapy Market Revenues & Volume, By Autologous CAR T-Cells, 2021- 2031F |
6.2 India CAR T-Cell Immunotherapy Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 India CAR T-Cell Immunotherapy Market Revenues & Volume, By Diffuse Large B-Cell Lymphoma, 2021- 2031F |
6.2.3 India CAR T-Cell Immunotherapy Market Revenues & Volume, By Acute Lymphoblastic Leukemia, 2021- 2031F |
6.3 India CAR T-Cell Immunotherapy Market, By Target Antigen |
6.3.1 Overview and Analysis |
6.3.2 India CAR T-Cell Immunotherapy Market Revenues & Volume, By CD19, 2021- 2031F |
6.3.3 India CAR T-Cell Immunotherapy Market Revenues & Volume, By CD22, 2021- 2031F |
6.4 India CAR T-Cell Immunotherapy Market, By End Users |
6.4.1 Overview and Analysis |
6.4.2 India CAR T-Cell Immunotherapy Market Revenues & Volume, By Hospital, 2021- 2031F |
6.4.3 India CAR T-Cell Immunotherapy Market Revenues & Volume, By Diagnostic Center, 2021- 2031F |
7 India CAR T-Cell Immunotherapy Market Import-Export Trade Statistics |
7.1 India CAR T-Cell Immunotherapy Market Export to Major Countries |
7.2 India CAR T-Cell Immunotherapy Market Imports from Major Countries |
8 India CAR T-Cell Immunotherapy Market Key Performance Indicators |
8.1 Number of clinical trials and research studies related to CAR T-cell therapy in India |
8.2 Adoption rate of immunotherapy treatments in cancer centers |
8.3 Number of partnerships and collaborations between pharmaceutical companies and research institutions in the field of CAR T-cell therapy. |
9 India CAR T-Cell Immunotherapy Market - Opportunity Assessment |
9.1 India CAR T-Cell Immunotherapy Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 India CAR T-Cell Immunotherapy Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 India CAR T-Cell Immunotherapy Market Opportunity Assessment, By Target Antigen, 2021 & 2031F |
9.4 India CAR T-Cell Immunotherapy Market Opportunity Assessment, By End Users, 2021 & 2031F |
10 India CAR T-Cell Immunotherapy Market - Competitive Landscape |
10.1 India CAR T-Cell Immunotherapy Market Revenue Share, By Companies, 2024 |
10.2 India CAR T-Cell Immunotherapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here